INTERMEDIATE-RISK PE

Moderator(s)

• 

  Saher Sabri, MD

  Chief of Interventional Radiology
  MedStar Georgetown University Hospital
  Interventional Radiology
  Washington, District of Columbia, United States

  Disclosure(s): Boston Scientific: Consultant
  Inquis: Grants/Research Support Recipient
  Medtronic: Consultant
• 

  Akhilesh Sista, MD

  Professor
  Weill Cornell Medicine
  Interventional Radiology
  New York, New York, United States

  Disclosure(s): No financial relationships to disclose

Panel(s)

• 

  Iris Baumgartner, MD

  Co-Founder / MD
  Bern Center for Vascular Medicine and Intervention, Vasc Alliance AG
  Angiology
  Bern, Switzerland

  Disclosure(s): No financial relationships to disclose
• 

  Rabih Chaer, MD, MSc

  Chief, Division of Vascular Surgery
  Stony Brook Medicine
  Vascular Surgery
  Stony Brook, New York, United States

  Disclosure(s): No financial relationships to disclose
• 

  Daniella Kadian-Dodov, MD

  Associate Professor of Medicine
  Icahn School of Medicine at Mount Sinai
  Vascular Medicine
  New York, New York, United States

  Disclosure(s): Abbott Vascular: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
  Boston Scientific: Advisory Board; Consultant; Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
  Zevra Therapeutics: Advisory Board
• 

  Sahil Parikh, MD

  Director, Endovascular Services
  New York Presbyterian/Columbia University Irving Medical Center
  Interventional Cardiology
  New York, New York, United States

  Disclosure(s): Abbott Vascular: Advisory Board; Grants/Research Support Recipient; Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
  Acotec: Grants/Research Support Recipient
  AVS: Grants/Research Support Recipient
  Boston Scientific: Advisory Board; Consultant; Grants/Research Support Recipient
  Cagent: Grants/Research Support Recipient
  Concept Medical: Advisory Board; Grants/Research Support Recipient
  Cordis: Advisory Board
  Inari Medical: Advisory Board
  Medinol: Grants/Research Support Recipient
  Medtronic: Advisory Board
  Penumbra: Advisory Board; Grants/Research Support Recipient
  Philips: Advisory Board; Grants/Research Support Recipient
  R3 Vascular: Advisory Board; Grants/Research Support Recipient
  Reflow: Grants/Research Support Recipient
  Reflow Medical: Grants/Research Support Recipient
  Shockwave: Advisory Board; Grants/Research Support Recipient; Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
  Terumo: Consultant
  Veryan: Grants/Research Support Recipient

Presentations:

• 3:30pm - 3:37pm PT

  How I Approach the Stable Intermediate-Risk PE Patient
  

  Speaker: Daniella Kadian-Dodov, MD – Icahn School of Medicine at Mount Sinai
• 3:37pm - 3:42pm PT

  Panel Discussion
• 3:42pm - 3:49pm PT

  How I Approach the Unstable Intermediate-Risk PE Patient
  

  Speaker: Rabih Chaer, MD, MSc – Stony Brook Medicine
• 3:49pm - 3:54pm PT

  Panel Discussion
• 3:54pm - 4:01pm PT

  Does Systemic Thrombolysis Still Have a Role in the Treatment of Intermediate-Risk PE?
  

  Speaker: Iris Baumgartner, MD – Bern Center for Vascular Medicine and Intervention, Vasc Alliance AG
• 4:01pm - 4:06pm PT

  Panel Discussion
• 4:06pm - 4:13pm PT

  Debate: Mechanical Thrombectomy Is Superior to Catheter-Directed Thrombolysis for Intermediate-Risk PE
  

  Speaker: Sahil A. Parikh, MD – New York Presbyterian/Columbia University Irving Medical Center
• 4:13pm - 4:20pm PT

  Debate: Mechanical Thrombectomy Has Yet to Prove Itself Better Than Catheter-Directed Thrombolysis
  

  Speaker: Akhilesh Sista, MD – Weill Cornell Medicine
• 4:20pm - 4:30pm PT

  Panel Discussion